_PRIVATELIMITED.webp)
Africure Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.04 M
as on 16-11-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.00 Cr
as on 16-11-2024
- Revenue 36.40%
(FY 2023)
- Profit -26.68%
(FY 2023)
- Ebitda -55.83%
(FY 2023)
- Net Worth 10.75%
(FY 2023)
- Total Assets -2.76%
(FY 2023)
About Africure Pharmaceuticals (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.04 M.
The company currently has active open charges totaling ₹13.50 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Susan Noronha, Ravi Chandrasekhar, and Sanskar Tated serve as directors at the Company.
- CIN/LLPIN
U24303MH2017PTC291491
- Company No.
291491
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Africure Pharmaceuticals (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Susan Noronha  | Director | 26-Mar-2021 | Current |
| Ravi Chandrasekhar | Director | 21-Feb-2017 | Current |
| Sanskar Tated | Director | 21-Feb-2017 | Current |
Financial Performance of Africure Pharmaceuticals (India).
Africure Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.4% increase. The company also saw a substantial fall in profitability, with a 26.68% decrease in profit. The company's net worth Soared by an impressive increase of 10.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Africure Pharmaceuticals (India)?
In 2023, Africure Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parkes And Rao Research International Private LimitedActive 7 years 4 monthsRavi Chandrasekhar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Jan 2020 | ₹3.50 Cr | Open |
Hdfc Bank Limited Creation Date: 17 Dec 2019 | ₹10.00 Cr | Open |
Others Creation Date: 30 Mar 2017 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Africure Pharmaceuticals (India)?
Africure Pharmaceuticals (India) has a workforce of 126 employees as of Sep 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Africure Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Africure Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
